Latest Product Distribution News

BauMart Holdings reports progress in AI-driven international recruitment and sustainable building materials development, alongside a $180,000 capital raise to support growth initiatives.

OMG Group Limited reported a robust 56% year-on-year increase in quarterly cash receipts, driven by expanded product distribution and a strategic $2 million capital raise. The company is poised for further growth with new retail partnerships and a high-profile marketing campaign ahead of the summer sales season.

Baumart Holdings has recorded a nearly $1 million impairment on its mining equipment due to halted diamond mining operations and no clear plans for asset redeployment.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

Aumake Limited reported a strong 54% jump in revenue to nearly $40 million for FY25, while cutting its net loss by 45%. The company’s strategic pivot to higher-margin products and key distribution deals set the stage for an ambitious FY26.

BTC Health Limited reported a remarkable 277% increase in profit after tax to nearly $4 million for FY25, driven by significant fair value gains on its healthcare investments and key contract wins.

Vulcan Steel has reported preliminary FY25 earnings with stable EBITDA and reduced net debt, while highlighting cautious optimism for FY26 amid tough trading conditions.

TALi Digital has acquired the You Can Do It! education program, boosting its social-emotional learning portfolio, while raising $0.8 million through a private placement to support growth initiatives.

Buru Energy advances its Rafael Gas Project in Western Australia with a focus on sustainable growth, targeting a final investment decision in 2026 and production start in 2028. The project aims to supply local power generation with trucked LNG and condensate, replacing costly imports.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

Fletcher Building unveiled a comprehensive strategic review and FY25 outlook at its Investor Day, highlighting a focus on manufacturing and distribution alongside significant restructuring costs. The company targets a leaner operation with disciplined capital management and a net debt goal of NZD 400m to 900m.

The Calmer Co. International Limited has significantly expanded the distribution of its flagship kava products in Coles supermarkets, reflecting growing consumer appetite for natural relaxation alternatives to alcohol.